World Health Organisation - HIV guidelines
World Health Organisation - TB guidelines
National Department of Health
Listeriosis: Clinical recommendations for diagnosis and treatment
Please find attached the application form that is required to be completed for access to Third Line Antiretroviral Therapy. Please complete the form using the following steps:
• Download: Please download the PDF document.
• Open: Open the PDF document using Adobe Reader. Ensure you have the latest version of the form may not work properly.
• Fill: This is an editable PDF, and the minimum required fields will be highlighted. Please click on each field and enter the required patient information.
Please do not print out the document to complete by hand.
• Save: Once you have completed the document please save it to your computer by clicking the icon on the top left of the screen. Save it using the patient name and surname as a unique identifier.
• Submit: Close Adobe and attach the completed and renamed application form to an email and submit it to the following email address: TLART@health.gov.za
Department of Health
This Adolescent and Youth Health Policy aims to promote the health and well-being of young people, aged 10-24 years.
Prepared by the National Department of Health
The 2016 "Guidelines for Expanding Combination Prevention and Treatment Options for Sex Workers: Oral Pre-Exposure Prophylaxis (PrEP) and Test and Treat (T&T)" have been released by the SA National Department of Health.
This document, and the associated circular (FDC ARV Circular, dated 25.05.2015) provides guidance on how to prescribe FDCs. This reduces the need to use single-agent lamivudine tablets.
The PHC Standard Treatment Guidelines EML should be used at clinics, community health centres and gateway clinics for the management of conditions commonly presenting at this level.
The DoH requires that all third line drugs should be appropriately motivated for, using the form provided.
April 2015 guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults
There are four fixed-dose ARV combinations available. Here are the NDoH guidelines for their use in first and second-line ART regimens.
Sexually Transmitted Infections: NDOH Management Guidelines 2015
Additional Content to the National Sexually Transmitted Infections Care and Treatment Course for Health Care Workers
Includes STI guideline changes, national STI services results reporting and high transmission areas: key populations
National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults
NDOH circular on changes in the prescription of progestin subdermal implants (implanon) in women taking enzyme-inducing drugs such as efavirenz, rifampicin and certain epilepsy medicines.
Notice to public health facilities of a supplier shortage of NVP 100ml and 240ml
The latest National Tuberculosis Management Guidelines - 2014
Implementing all these strategies in combination will not only reduce the burden of disease in
children but help us attain the goal of zero TB deaths in children. Partnerships with communities
and more research into new diagnostic tests, better vaccines and child friendly medicine
formulations will provide immense opportunities for attaining this goal.
Circular issued by the National Department of Health stating that ALL eligible patient groups should be offered to switch to the fixed-dose combination of Tenofovir(TDF) + Emtricitabine (FTC)+ Efavirenz (EFV).
NDoH First Line Comprehensive Management and Control of Sexually Transmitted Infections
National Strategic Plan for HIV Prevention, Care and Treatment for Sex Workers First Edition 2013
NDOH protocol for accessing third-line antiretroviral therapy in the public sector
NDOH motivation form for third line ART
Algorithm for HIV-exposed and infected children, from HCT into care
Newly revised protocol for the management of health complaints in the public sector
NDOH algorithm for the management of HIV-exposed children
These are the latest complete ART guidelines from the National Department of Health. Official implementation date is the 1st of April 2013.
This document is a PDF version of the National Department of Health's Overview presentation of the latest ART guidelines, to be implemented from April 1st 2013. This includes the introduction of fixed dose combination regimens.
This document, published by the South African National Department of Health on 13 March 2013, contains several demonstrative case studies for trainers to teach the correct implementation of Fixed Dose Combination (FDC) regimens in terms of the latest guidelines. It includes several realistic case studies and the accompanying answers.
This document contains the short combined guidelines for antiretroviral treatment for South Africa in 2013. This document was published on 14 March 2013 by the National Department of Health. This includes standardised national guidelines for adults and adolescents, children, HIV-positive pregnant women as well as HIV-positive newborn infants.
This document, published by the South African National Department of Health on 13 March 2013, includes the departments standardised guidelines for implementation of Fixed Dose Combination (FDC) regimens. Thus its purpose is to update frontline clinical staff for the implementation of FDC guidelines in PMTCT, paediatric and adult ARV treatment.
These presentation slides, put together by the South African National Department of Health, should aid in training staff for the correct implementation of the 2013 standardised guidelines for Fixed Dose Combination (FDC) antiretroviral therapy regimens.
NDOH South Africa
World Health Organization
The guidelines fill a gap in providing tools for surveying HIV prevalence in key populations, and the included questionnaires may also inform general population surveys.
Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: second edition June 2016
WHO policy brief
WHO recommends assistance for people with HIV to notify their partners
WHO recommends HIV self-testing
Supplement to consolidated guidelines on HIV testing services
In this new consolidated guidelines document the World Health Organization brings together all existing guidance relevant to five key populations – men who have sex with men, people who inject drugs, people in prisons and other closed settings, sex workers and transgender people – and updates selected guidance and recommendations.
These WHO guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care.
These guidelines aim to reduce morbidity and mortality related to TB and HIV-associated TB among people who inject drugs (PWID) through the integrated delivery of a comprehensive and holistic package of care.
This report from UNAIDS and the WHO discusses the six elements of HIV prevention efforts that are crucial to achieve the target of reducing HIV incidence to 500 000 or fewer by 2020. commitment, focus, synergies, innovation, coverage and accountability
WHO's Sept 2015 guidelines
Update to 2007 guidance to include all types of migrants and crisis-affected populations,
including those forcibly displaced. This update stresses that migration and forced displacement
must NO T be used as an excuse to deny treatment. Clear recommendations are provided for states,
clinicians and programme managers, civil society, donors and United Nations (UN ) agencies.
The WHO has released its first ever set of guidelines for the prevention, care and treatment of persons with chronic hepatitis B (HBV) infection on 12 Mar 2015, following the publication of its guidelines on managing HCV in 2014.
The updated WHO Guidelines on post-exposure prophylaxis for HIV for adults, adolescents and children were launched in January 2015
The WHO Department of Maternal, Newborn, Child and Adolescent Health (MCA), in collaboration with the Department of HIV/AIDS, has developed these guidelines on the treatment of common
skin and oral conditions associated with HIV.